Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
World stock index performance today highlights current momentum across major markets. Use these readings to assess market tone and adjust exposure.
25,541 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Nvidia faces strong AI-driven demand and a robust roadmap that could push long-term targets higher. Analysts weigh ne...
Semiconductors have sprinted this year, but a cooling period is drawing attention. History suggests pauses can lead t...
CoreWeave reported a $740 million quarterly loss as it stacked up a record backlog and a massive Meta deal, underscor...
As 2026 unfolds, three robotics stocks stand out in the M&A spotlight, driven by cash flow, autonomous tech stacks, a...
Forward Industries jumped after confirming it expanded its SOL holdings by more than 500,000 coins. Here’s what this ...
Wildfire smoke blankets major U.S. cities, pushing air quality warnings higher and nudging investment flows toward cl...
NVIDIA's quarterly results come as tech stocks swing, with investors assessing data center demand, margins, and AI ec...
Credo Technology delivers a blockbuster Q3, yet Marvell’s AI data-center push steals the spotlight. Investors are ret...
Bank of America reinstates Buy on Microsoft, guiding toward a $500 price target as Azure growth and Copilot adoption ...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
Investigating the royal bank (ry) 2026 Q2 results reveals how the lender is balancing growth across retail, wealth, a...